Cerity Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Buy
64,979
+33,607
+107% +$1.57M ﹤0.01% 1219
2026
Q1
$1.13M Buy
+31,372
New +$1.31M ﹤0.01% 1791
2025
Q3
Sell
-85,729
Closed -$3.53M 2763
2025
Q2
$3.53M Buy
85,729
+62,777
+274% +$2.42M 0.01% 971
2025
Q1
$958K Sell
22,952
-5,830
-20% -$303K ﹤0.01% 1443
2024
Q4
$1.73M Buy
28,782
+784
+3% +$46.3K ﹤0.01% 1168
2024
Q3
$1.93M Buy
27,998
+22,878
+447% +$1.48M ﹤0.01% 1105
2024
Q2
$327K Buy
5,120
+873
+21% +$65.7K ﹤0.01% 1771
2024
Q1
$399K Buy
+4,247
New +$342K ﹤0.01% 1717

Other funds holding BRKR

Cerity Partners's BRKR Position: Q2 2026 in Review

Cerity Partners increased its Bruker (BRKR) stake by 107% in Q2 2026, buying an estimated $1.57M and bringing the position to 64,979 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Cerity Partners first reported a position in BRKR in Q1 2024 and has held it in 8 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Cerity Partners held 64,979 shares of Bruker worth $3.91M as of Q2 2026.
  • Cerity Partners bought 33,607 Bruker shares in Q2 2026, an estimated $1.57M.
  • Bruker made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1219 holding.
  • Cerity Partners first reported a position in Bruker in Q1 2024 and has held it in 8 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.